Barclays »

Cadrenal Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $311 93 3.34

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Cadrenal Therapeutics

Vanguard Capital Management
Hrt Financial
Geode Capital Management
Vanguard Fiduciary Trust
Tower Research Capital
UBS Group
Coconut Grove Bank
Hartland & Co
Quest 10 Wealth Builders
Advisor Group Holdings
Rockefeller Capital Management
Morgan Stanley
Wells Fargo & Company
Barclays
Archer Investment Corp

View all funds holding Cadrenal Therapeutics